000504 *ST生物
已收盘 02-13 15:00:00
资讯
新帖
简况
每周股票复盘：*ST生物（000504）或面临终止上市风险
证券之星 · 02-08
每周股票复盘：*ST生物（000504）或面临终止上市风险
*ST生物（000504）披露股票可能被终止上市的第二次风险提示公告，2月5日股价下跌0.89%
证券之星 · 02-05
*ST生物（000504）披露股票可能被终止上市的第二次风险提示公告，2月5日股价下跌0.89%
*ST生物（000504）披露召开2026年第一次临时股东大会通知，1月26日股价上涨2.15%
证券之星 · 01-26
*ST生物（000504）披露召开2026年第一次临时股东大会通知，1月26日股价上涨2.15%
每周股票复盘：*ST生物（000504）预计2025年净利2850万至3250万元
证券之星 · 01-25
每周股票复盘：*ST生物（000504）预计2025年净利2850万至3250万元
*ST生物（000504）披露股票可能被终止上市的风险提示公告，1月22日股价上涨0.32%
证券之星 · 01-22
*ST生物（000504）披露股票可能被终止上市的风险提示公告，1月22日股价上涨0.32%
*ST生物(000504.SZ)发预盈，预计2025年归母净利润2850万元–3250万元，扭亏为盈
智通财经 · 01-22
*ST生物(000504.SZ)发预盈，预计2025年归母净利润2850万元–3250万元，扭亏为盈
*ST生物最新公告：终止筹划重大资产重组
证券之星 · 01-22
*ST生物最新公告：终止筹划重大资产重组
异动快报：*ST生物（000504）1月19日13点35分触及涨停板
证券之星 · 01-19
异动快报：*ST生物（000504）1月19日13点35分触及涨停板
股市必读：*ST生物（000504）1月14日董秘有最新回复
证券之星 · 01-15
股市必读：*ST生物（000504）1月14日董秘有最新回复
每周股票复盘：*ST生物（000504）拟收购慧泽医药51%股权
证券之星 · 01-11
每周股票复盘：*ST生物（000504）拟收购慧泽医药51%股权
*ST生物（000504）披露开展商品期货套期保值业务公告，1月5日股价下跌1.45%
证券之星 · 01-05
*ST生物（000504）披露开展商品期货套期保值业务公告，1月5日股价下跌1.45%
每周股票复盘：*ST生物（000504）非独立董事辞职
证券之星 · 2025-12-28
每周股票复盘：*ST生物（000504）非独立董事辞职
*ST生物（000504）披露非独立董事辞职公告，12月25日股价下跌1.0%
证券之星 · 2025-12-25
*ST生物（000504）披露非独立董事辞职公告，12月25日股价下跌1.0%
异动快报：*ST生物（000504）12月17日10点24分触及跌停板
证券之星 · 2025-12-17
异动快报：*ST生物（000504）12月17日10点24分触及跌停板
*ST生物（000504）发布公司公告披露聘请2025年度审计机构，12月16日股价下跌3.24%
证券之星 · 2025-12-16
*ST生物（000504）发布公司公告披露聘请2025年度审计机构，12月16日股价下跌3.24%
*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%
证券之星 · 2025-11-28
*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%
每周股票复盘：*ST生物（000504）完成2341.44万元债权转让
证券之星 · 2025-11-23
每周股票复盘：*ST生物（000504）完成2341.44万元债权转让
*ST生物：慧泽医药核心业务为药物研发及临床评价服务
证券之星 · 2025-11-20
*ST生物：慧泽医药核心业务为药物研发及临床评价服务
*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务
证券之星 · 2025-11-20
*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务
*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%
证券之星 · 2025-11-20
*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%
加载更多
公司概况
公司名称：
南华生物医药股份有限公司
所属行业：
科技推广和应用服务业
上市日期：
1992-12-08
主营业务：
南华生物医药股份有限公司的主营业务是细胞医疗服务。公司的主要产品是新生儿干细胞储存和成人免疫细胞储存服务。
发行价格：
1.00
{"stockData":{"symbol":"000504","market":"SZ","secType":"STK","nameCN":"*ST生物","latestPrice":8.62,"timestamp":1770966216000,"preClose":8.66,"halted":0,"volume":2000500,"delay":0,"changeRate":-0.0046,"floatShares":329000000,"shares":330000000,"eps":-0.0188,"marketStatus":"已收盘","change":-0.04,"latestTime":"02-13 15:00:00","open":8.69,"high":8.75,"low":8.6,"amount":17335500,"amplitude":0.0173,"askPrice":8.63,"askSize":270,"bidPrice":8.62,"bidSize":39,"shortable":0,"etf":0,"ttmEps":-0.0188,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.66,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":9.09,"lowLimit":8.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":330023098,"isCdr":false,"pbRate":11.79,"roa":"--","roe":"2.18%","epsLYR":-0.06,"committee":-0.2,"marketValue":2845000000,"turnoverRate":0.0061,"status":1,"floatMarketCap":2837000000},"requestUrl":"/m/hq/s/000504","defaultTab":"news","newsList":[{"id":"2609620526","title":"每周股票复盘：*ST生物（000504）或面临终止上市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2609620526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609620526?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:55","pubTimestamp":1770490511,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，*ST生物报收于8.76元，较上周的8.67元上涨1.04%。本周关注点公司公告汇总：南华生物因财务指标不达标，股票可能被终止上市。若2025年度经审计的财务指标仍不符合规定，公司股票存在被终止上市的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0086","BK0282","000504"],"gpt_icon":0},{"id":"2609912301","title":"*ST生物（000504）披露股票可能被终止上市的第二次风险提示公告，2月5日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609912301","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609912301?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:40","pubTimestamp":1770302430,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，*ST生物报收于8.89元，较前一交易日下跌0.89%，最新总市值为29.34亿元。近日，*ST生物发布《股票可能被终止上市的第二次风险提示公告》。若2025年度经审计的财务指标仍不符合规定，公司股票存在被终止上市的风险。公司已在指定媒体发布相关风险提示公告，提醒投资者注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0086","BK0046","000504"],"gpt_icon":0},{"id":"2606249279","title":"*ST生物（000504）披露召开2026年第一次临时股东大会通知，1月26日股价上涨2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606249279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606249279?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:57","pubTimestamp":1769439446,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，*ST生物报收于9.04元，较前一交易日上涨2.15%，最新总市值为29.83亿元。该股当日开盘8.83元，最高9.08元，最低8.76元，成交额达6523.07万元，换手率为2.23%。近日，*ST生物发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年2月12日召开2026年第一次临时股东会，会议由公司董事会召集，现场会议地点为长沙高新开发区岳麓西大道1698号麓谷科技创新创业园B1栋三层会议室。股权登记日为2026年2月6日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600037050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0282","BK0042","BK0046","BK0086"],"gpt_icon":0},{"id":"2606523286","title":"每周股票复盘：*ST生物（000504）预计2025年净利2850万至3250万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606523286","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606523286?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:14","pubTimestamp":1769278452,"startTime":"0","endTime":"0","summary":"本周关注点业绩披露要点：*ST生物预计2025年归属净利润盈利2850万元至3250万元。预计2025年全年归属净利润盈利2,850万元至3,250万元。南华生物预计2025年度实现利润总额盈利1,850万元至2,650万元，归属于上市公司股东的净利润盈利2,850万元至3,250万元，扣除非经常性损益后的净利润盈利850万元至1,250万元，营业收入预计为38,500万元至42,500万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0282","000504","BK0042"],"gpt_icon":0},{"id":"2605903044","title":"*ST生物（000504）披露股票可能被终止上市的风险提示公告，1月22日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605903044","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605903044?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:49","pubTimestamp":1769093350,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，*ST生物报收于9.3元，较前一交易日上涨0.32%，最新总市值为30.69亿元。近日，*ST生物发布关于股票可能被终止上市的风险提示公告。若2025年度经审计的财务指标仍不符合规定，公司股票存在被终止上市的风险。公司将按规定持续披露风险提示公告，提醒投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0042","BK0282","BK0086"],"gpt_icon":0},{"id":"2605993874","title":"*ST生物(000504.SZ)发预盈，预计2025年归母净利润2850万元–3250万元，扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2605993874","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605993874?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:54","pubTimestamp":1769086490,"startTime":"0","endTime":"0","summary":"智通财经APP讯，*ST生物(000504.SZ)披露2025年年度业绩预告，公司预计归属于上市公司股东的净利润2850万元–3250万元，扭亏为盈;扣除非经常性损益后的净利润850万元–1250万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"*ST生物(000504.SZ)发预盈，预计2025年归母净利润2850万元–3250万元，扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000504"],"gpt_icon":0},{"id":"2605495139","title":"*ST生物最新公告：终止筹划重大资产重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495139","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605495139?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:09","pubTimestamp":1769083780,"startTime":"0","endTime":"0","summary":"*ST生物(000504.SZ)公告称，公司与交易各方签署了《股权收购意向协议之终止协议》，终止筹划收购湖南慧泽生物医药科技有限公司51%股权的重大资产重组事项。本次交易尚未进入正式实施阶段，交易各方未达成实质性协议。公司承诺至少一个月内不再筹划重大资产重组事项。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200036879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0282","BK0042","BK0086"],"gpt_icon":0},{"id":"2604290711","title":"异动快报：*ST生物（000504）1月19日13点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2604290711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604290711?lang=zh_cn&edition=full","pubTime":"2026-01-19 13:40","pubTimestamp":1768801231,"startTime":"0","endTime":"0","summary":"证券之星1月19日盘中消息，13点35分*ST生物触及涨停板。其所属行业医疗服务目前下跌。领涨股为新里程。该股为国企改革，湖南国企改革，智慧城市概念热股，当日国企改革概念上涨1.22%，湖南国企改革概念上涨1.18%。1月16日的资金流向数据方面，主力资金净流出733.1万元，占总成交额35.45%，游资资金净流入486.82万元，占总成交额23.54%，散户资金净流入246.29万元，占总成交额11.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900013549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0042","000504","BK0282"],"gpt_icon":0},{"id":"2603649597","title":"股市必读：*ST生物（000504）1月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603649597","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603649597?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:50","pubTimestamp":1768416618,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，*ST生物报收于8.52元，下跌0.93%，换手率0.85%，成交量2.79万手，成交额2379.93万元。是否属于本月没有进展，导致两篇公告仅修改一些用词，避免重复。公司重组进展公告严格遵循监管要求，客观反映进展情况。后续公司将根据实际进展情况及时履行相关披露义务，相关情况请以公司在指定媒体披露的公告为准。当日关注点来自交易信息汇总：1月14日主力资金净流出464.63万元，显示主力短期减持动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500001510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0042","000504","BK0282"],"gpt_icon":0},{"id":"2602853674","title":"每周股票复盘：*ST生物（000504）拟收购慧泽医药51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2602853674","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602853674?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:17","pubTimestamp":1768076227,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，*ST生物报收于8.84元，较上周的8.95元下跌1.23%。本周关注点公司公告汇总：*ST生物拟以现金收购湖南慧泽生物医药科技有限公司51%股权，交易构成重大资产重组。该事项已获董事会审议通过，不涉及关联交易，无需提交股东大会审议。亏损达净利润10%且超1000万元时需披露原因及套期有效性评估。南华生物拟以现金方式收购湖南慧泽生物医药科技有限公司51%股权，交易完成后慧泽医药将成为公司控股子公司并纳入合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK0086","BK0046","BK0282","BK1515","BK1161","000504","BK0042","BK1574","159938"],"gpt_icon":0},{"id":"2601007161","title":"*ST生物（000504）披露开展商品期货套期保值业务公告，1月5日股价下跌1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601007161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601007161?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:58","pubTimestamp":1767607107,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，*ST生物报收于8.82元，较前一交易日下跌1.45%，最新总市值为29.11亿元。公司表示，此次套期保值业务旨在对冲原材料价格波动风险，锁定经营利润，不以投机为目的，并已制定相应风险控制措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500027051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0086","BK0046","BK0282","BK0042"],"gpt_icon":0},{"id":"2594148242","title":"每周股票复盘：*ST生物（000504）非独立董事辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2594148242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594148242?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:08","pubTimestamp":1766866093,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，*ST生物报收于9.2元，较上周的8.47元上涨8.62%。本周关注点公司公告汇总：非独立董事陈文博因个人原因辞职，不再担任公司任何职务。公司公告汇总南华生物董事会近日收到非独立董事陈文博的书面辞职申请，其因个人原因辞去第十二届董事会非独立董事职务，并一并辞去董事会战略委员会委员及提名委员会委员职务，辞职后不再担任公司任何职务。陈文博未持有公司股票，无未履行承诺事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0282","BK0042","BK0046","BK0086"],"gpt_icon":0},{"id":"2594363702","title":"*ST生物（000504）披露非独立董事辞职公告，12月25日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594363702","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594363702?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:47","pubTimestamp":1766656041,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，南华生物医药股份有限公司董事会于近日收到非独立董事陈文博先生的书面辞职申请。陈文博先生因个人原因申请辞去公司第十二届董事会非独立董事职务，一并辞去董事会战略委员会委员及提名委员会委员职务，辞职后不再担任公司任何职务。其辞职报告自送达公司董事会之日起生效。陈文博先生未持有公司股票，不存在应当履行而未履行的承诺事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0282","000504","BK0086"],"gpt_icon":0},{"id":"2592957883","title":"异动快报：*ST生物（000504）12月17日10点24分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2592957883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592957883?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:25","pubTimestamp":1765938324,"startTime":"0","endTime":"0","summary":"证券之星12月17日盘中消息，10点24分*ST生物（000504）触及跌停板。其所属行业医疗服务目前上涨。领涨股为美年健康。该股为湖南国企改革，干细胞，国企改革概念热股，当日湖南国企改革概念上涨0.16%。12月16日的资金流向数据方面，主力资金净流出168.94万元，占总成交额11.04%，游资资金净流出31.17万元，占总成交额2.04%，散户资金净流入200.11万元，占总成交额13.08%。近5日资金流向一览见下表：*ST生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700009607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0042","BK0086","BK0282"],"gpt_icon":0},{"id":"2591988250","title":"*ST生物（000504）发布公司公告披露聘请2025年度审计机构，12月16日股价下跌3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591988250?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:54","pubTimestamp":1765878894,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，*ST生物报收于8.67元，较前一交易日下跌3.24%，最新总市值为28.61亿元。公司近日发布公告称，南华生物医药股份有限公司于2025年12月15日召开2025年第四次临时股东会，会议由董事会召集，董事长杨云主持，采用现场与网络投票结合方式召开。出席会议股东共238人，代表股份151,117,932股，占公司有表决权股份总数的45.7901%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600030142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0282","BK0042","BK0046","000504","BK0086"],"gpt_icon":0},{"id":"2586332067","title":"*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586332067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586332067?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:37","pubTimestamp":1764340667,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，*ST生物报收于9.35元，较前一交易日上涨0.21%，最新总市值为30.86亿元。该股当日开盘9.33元，最高9.42元，最低9.26元，成交额达1149.11万元，换手率为0.37%。近日，南华生物发布公告称，公司将于2025年12月15日召开2025年第四次临时股东会，会议由董事会召集，现场会议地点为长沙高新开发区岳麓西大道1698号麓谷科技创新创业园B1栋三层会议室。股权登记日为2025年12月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0282","BK0046","BK0086","BK0042","000504"],"gpt_icon":0},{"id":"2585063921","title":"每周股票复盘：*ST生物（000504）完成2341.44万元债权转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2585063921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585063921?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:27","pubTimestamp":1763843230,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，*ST生物报收于9.36元，较上周的10.23元下跌8.5%。本周，*ST生物11月17日盘中最高价报10.26元。*ST生物当前最新总市值30.89亿元，在医疗服务板块市值排名47/50，在两市A股市值排名4426/5167。本周关注点公司公告汇总：南华生物全资子公司已收到2,341.44万元债权转让款，交易完成。该债权资产截至2024年12月31日经审计的账面价值为2,341.44万元，财信资产以不低于该金额的对价受让。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0282","BK0046","000504"],"gpt_icon":0},{"id":"2584548131","title":"*ST生物：慧泽医药核心业务为药物研发及临床评价服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2584548131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584548131?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642934,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物(000504)11月20日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，慧泽生物有哪些创新药产品？*ST生物回复：尊敬的投资者，您好！公司筹划收购的慧泽医药为专业CRO服务公司，核心业务为药物研发及临床评价服务（85%以上收入来源）。相关业务详情请以公司在指定媒体披露的公告为准。敬请广大投资者注意投资风险。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0282","BK1515","BK1574","159938","BK1161","09939","BK0086","000504"],"gpt_icon":0},{"id":"2584113155","title":"*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2584113155","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584113155?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642930,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物11月20日在投资者关系平台上答复投资者关心的问题。请详细介绍一下收购的这家公司相关业务继续未来战略方向。*ST生物回复：尊敬的投资者，您好！公司以自有资金4,862.49万元收购娄底金弘新材料有限公司43.05%股权，并同步增资3,000万元，持股比例达55%并取得控制权。本次交易旨在切入废旧动力电池回收等新能源相关业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0042","BK0282","BK0086","159703"],"gpt_icon":0},{"id":"2584918735","title":"*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584918735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584918735?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:48","pubTimestamp":1763632110,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，*ST生物报收于9.59元，较前一交易日下跌0.93%，最新总市值为31.65亿元。该债权资产截至2024年12月31日经审计的账面价值为2,341.44万元，财信资产以不低于该金额的对价受让。截至公告日，公司全资子公司南华干细胞再生医学临床转化研究中心有限责任公司已收到财信资产支付的全部债权转让款2,341.44万元，交易已完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000026963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0282","BK0042","BK0086"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771602462881,"stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":0.0117},{"period":"3month","weight":-0.1574},{"period":"6month","weight":-0.159},{"period":"1year","weight":-0.0849},{"period":"ytd","weight":-0.0369}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南华生物医药股份有限公司","boardCode":"AI0075","boardName":"科技推广和应用服务业","stockholders":"12189人(较上一季度减少7.93%)","perCapita":"27001股","listingDate":"1992-12-08","address":"湖南省长沙市岳麓区高新区岳麓西大道1698号麓谷科技创新创业园B1栋3楼","registeredCapital":"33002万元","survey":" 南华生物医药股份有限公司的主营业务是细胞医疗服务。公司的主要产品是新生儿干细胞储存和成人免疫细胞储存服务。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST生物,000504,*ST生物股票,*ST生物股票老虎,*ST生物股票老虎国际,*ST生物行情,*ST生物股票行情,*ST生物股价,*ST生物股市,*ST生物股票价格,*ST生物股票交易,*ST生物股票购买,*ST生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}